+794.9%
MRNA vs VG
+63.8%
+731.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.9% | -2.5% | -3.6% |
| 7D | -12.1% | +14.0% | -26.1% | -9.8% |
| 30D | -1.3% | -1.0% | -0.3% | -0.7% |
| 3M | +250.9% | -2.7% | +253.6% | +253.0% |
| 6M | +343.0% | +1.5% | +341.5% | +347.8% |
| YTD | +657.4% | +93.7% | +563.7% | +511.1% |
| 1Y | +794.9% | +68.5% | +726.4% | +665.3% |
| All | +794.9% | +63.8% | +731.2% | +665.3% |
Cumulative growth
Daily Returns
Daily percentage return beside VG.
Daily Out/Under-Performance
Portfolio return minus VG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling